Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Oncolytics Biotech Inc. (ONCY) had Return on Equity of -12521.93% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-10.45M |
|
-- |
|
-- |
|
$10.05M |
|
$-10.05M |
|
$-0.59M |
|
$-10.64M |
|
$-10.64M |
|
$-10.45M |
|
$-10.45M |
|
$-10.45M |
|
$-10.45M |
|
$-10.05M |
|
$-9.98M |
|
101.31M |
|
101.31M |
|
$-0.10 |
|
$-0.10 |
|
| Balance Sheet Financials | |
$10.20M |
|
$0.24M |
|
$0.73M |
|
$10.93M |
|
$5.56M |
|
-- |
|
$5.29M |
|
$10.85M |
|
$0.08M |
|
$0.08M |
|
$0.08M |
|
103.64M |
|
| Cash Flow Statement Financials | |
$-13.52M |
|
$-0.01M |
|
$11.18M |
|
$11.57M |
|
$8.97M |
|
$-2.61M |
|
$4.25M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.84 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-13.52M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-12521.93% |
-12521.67% |
|
-95.64% |
|
-12521.74% |
|
$0.00 |
|
$-0.13 |
|
$-0.13 |
|